(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 27% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.84%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.05%.
Clearpoint Neuro's revenue in 2026 is $40,614,000.On average, 5 Wall Street analysts forecast CLPT's revenue for 2026 to be $1,625,314,356, with the lowest CLPT revenue forecast at $1,528,268,130, and the highest CLPT revenue forecast at $1,694,110,414. On average, 5 Wall Street analysts forecast CLPT's revenue for 2027 to be $1,957,718,673, with the lowest CLPT revenue forecast at $1,763,386,304, and the highest CLPT revenue forecast at $2,138,105,894.
In 2028, CLPT is forecast to generate $2,312,555,182 in revenue, with the lowest revenue forecast at $2,221,866,744 and the highest revenue forecast at $2,380,571,511.